Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7764420rdf:typepubmed:Citationlld:pubmed
pubmed-article:7764420lifeskim:mentionsumls-concept:C0004632lld:lifeskim
pubmed-article:7764420lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:7764420lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:7764420lifeskim:mentionsumls-concept:C1519889lld:lifeskim
pubmed-article:7764420pubmed:issue12lld:pubmed
pubmed-article:7764420pubmed:dateCreated1994-3-22lld:pubmed
pubmed-article:7764420pubmed:abstractTextMany pathogens have the ability to vary the antigenic composition of surface-associated antigens. Often, this variation is mediated by the regulation of gene expression. By varying its antigenicity, the pathogen is able to avoid host immune responses more efficiently; however, this makes the design of vaccines against pathogens that exhibit antigenic variation difficult. In this review, we use the pathogenic Neisseria as an example of antigenically variable bacteria and discuss some attempts to overcome the problems of vaccine design posed by such organisms.lld:pubmed
pubmed-article:7764420pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7764420pubmed:languageenglld:pubmed
pubmed-article:7764420pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7764420pubmed:citationSubsetBlld:pubmed
pubmed-article:7764420pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7764420pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7764420pubmed:statusMEDLINElld:pubmed
pubmed-article:7764420pubmed:monthDeclld:pubmed
pubmed-article:7764420pubmed:issn0167-7799lld:pubmed
pubmed-article:7764420pubmed:authorpubmed-author:DouganGGlld:pubmed
pubmed-article:7764420pubmed:authorpubmed-author:FrankelGGlld:pubmed
pubmed-article:7764420pubmed:authorpubmed-author:MaskellDDlld:pubmed
pubmed-article:7764420pubmed:issnTypePrintlld:pubmed
pubmed-article:7764420pubmed:volume11lld:pubmed
pubmed-article:7764420pubmed:ownerNLMlld:pubmed
pubmed-article:7764420pubmed:authorsCompleteYlld:pubmed
pubmed-article:7764420pubmed:pagination506-10lld:pubmed
pubmed-article:7764420pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:7764420pubmed:meshHeadingpubmed-meshheading:7764420-...lld:pubmed
pubmed-article:7764420pubmed:meshHeadingpubmed-meshheading:7764420-...lld:pubmed
pubmed-article:7764420pubmed:meshHeadingpubmed-meshheading:7764420-...lld:pubmed
pubmed-article:7764420pubmed:meshHeadingpubmed-meshheading:7764420-...lld:pubmed
pubmed-article:7764420pubmed:year1993lld:pubmed
pubmed-article:7764420pubmed:articleTitlePhase and antigenic variation--the impact on strategies for bacterial vaccine design.lld:pubmed
pubmed-article:7764420pubmed:affiliationDepartment of Biochemistry, Imperial College of Science, Technology and Medicine, London, UK.lld:pubmed
pubmed-article:7764420pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7764420pubmed:publicationTypeReviewlld:pubmed
pubmed-article:7764420pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7764420lld:pubmed